A novel online calculator based on noninvasive markers (ALBI and APRI) for predicting post-hepatectomy liver failure in patients with hepatocellular carcinoma

Jinyu Shi(Capital Medical University), Tian Yang(Second Military Medical University), Feng Shen(Second Military Medical University), Wan Yee Lau(Chinese University of Hong Kong), Timothy M. Pawlik(The Ohio State University), Nan-Ya Wang(Jilin University), Bing Quan(Fudan University), Lei Liang(Zhejiang Provincial People's Hospital), Wei‐Min Gu(Harbin Medical University), Chao Li(Qingdao University), Hong Wang(Shanghai University of Traditional Chinese Medicine), Hao Xing(Second Military Medical University), Li‐Yang Sun(Unknown), Ya-Hao Zhou(Puer University), Ting‐Hao Chen(National Taiwan University)
Clinics and Research in Hepatology and Gastroenterology
October 13, 2020
10.1016/j.clinre.2020.09.001
Cited by 33

Related Papers

Exome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomas
|Nature Genetics|2013|709
Risk Factors, Patterns, and Outcomes of Late Recurrence After Liver Resection for Hepatocellular Carcinoma
|JAMA Surgery|2018|546
Sarcopenia negatively impacts short-term outcomes in patients undergoing hepatic resection for colorectal liver metastasis
|HPB|2011|413
Plasma metabolomic and lipidomic alterations associated with COVID-19
|National Science Review|2020|367
Future cancer research priorities in the USA: a Lancet Oncology Commission
|The Lancet Oncology|2017|209